mitomycin has been researched along with Complication, Intraoperative in 48 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate and compare the recurrence rates and complications between 2 therapeutic methods for primary pterygium: subconjunctival injection of mitomycin C (MMC) 1 month before bare scleral excision and conjunctival rotational flap with intraoperative MMC use." | 9.14 | Preoperative subpterygeal injection vs intraoperative mitomycin C for pterygium removal: comparison of results and complications. ( Daneshvar, R; Ghate, MF; Ghooshkhanehi, H; Khakshoor, H; Razavi, ME; Shakeri, MT, 2010) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 7.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "To evaluate the safety and efficacy of using fibrin glue in cases of recurrent pterygium treated with pterygium excision and conjunctival autograft combined with mitomycin C." | 7.77 | Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue. ( Boimer, C; Lee, K; Shehadeh-Mashor, R; Slomovic, AR; Srinivasan, S; Tomkins, O, 2011) |
| "Topography-guided PRK with mitomycin C was safe and reasonably effective for the treatment of hyperopia after RK." | 7.74 | Customized topography-guided photorefractive keratectomy with the MEL-70 platform and mitomycin C to correct hyperopia after radial keratotomy. ( de Souza, DC; Ghanem, EA; Ghanem, RC; Ghanem, VC; Kara-José, N, 2008) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 7.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "Combined BGI and mitomycin C trabeculectomy provides excellent postoperative IOP control in patients with refractory glaucoma." | 7.71 | Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002) |
| "The authors reviewed the charts of all patients of refractory developmental glaucoma who underwent mitomycin C-augmented trabeculectomy (0." | 7.70 | Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999) |
| "To evaluate and compare the recurrence rates and complications between 2 therapeutic methods for primary pterygium: subconjunctival injection of mitomycin C (MMC) 1 month before bare scleral excision and conjunctival rotational flap with intraoperative MMC use." | 5.14 | Preoperative subpterygeal injection vs intraoperative mitomycin C for pterygium removal: comparison of results and complications. ( Daneshvar, R; Ghate, MF; Ghooshkhanehi, H; Khakshoor, H; Razavi, ME; Shakeri, MT, 2010) |
| "The purpose of the study is to determine whether the intraoperative application of subconjunctival mitomycin C (MMC), during combined phacoemulsification and trabeculectomy, is an effective means of improving filtration, defined as overall lower intraocular pressure (IOP) and less antiglaucoma medication use." | 5.08 | A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. ( Alward, WL; Barad, JP; Carlson, DW; Carney, BL; Zimmerman, MB, 1997) |
| "To evaluate the efficacy, refractive predictability and stability, and complications of photorefractive keratectomy (PRK) with adjunctive mitomycin C (MMC) in patients with postkeratoplasty anisometropia." | 3.79 | Photorefractive keratectomy modification of postkeratoplasty anisometropic refractive errors. ( Goins, KM; Kitzmann, AS; Sutphin, JE; Wagoner, MD; Wandling, GR; Ward, MS, 2013) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 3.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "To evaluate the safety and efficacy of using fibrin glue in cases of recurrent pterygium treated with pterygium excision and conjunctival autograft combined with mitomycin C." | 3.77 | Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue. ( Boimer, C; Lee, K; Shehadeh-Mashor, R; Slomovic, AR; Srinivasan, S; Tomkins, O, 2011) |
| "To assess the safety and efficacy of photorefractive keratectomy with mitomycin C (PRK-MMC) to correct refractive errors after corneal transplantation." | 3.76 | Photorefractive keratectomy with mitomycin C after penetrating and lamellar keratoplasty. ( Forseto, Ados S; Marques, JC; Nosé, W, 2010) |
| "Topography-guided PRK with mitomycin C was safe and reasonably effective for the treatment of hyperopia after RK." | 3.74 | Customized topography-guided photorefractive keratectomy with the MEL-70 platform and mitomycin C to correct hyperopia after radial keratotomy. ( de Souza, DC; Ghanem, EA; Ghanem, RC; Ghanem, VC; Kara-José, N, 2008) |
| "The aim of the study was to assess the outcomes of surgical revision with reopening of the scleral flap in eyes with failed glaucoma surgery and adjunctive mitomycin C (MMC)." | 3.74 | Surgical revision of failed filtration surgery with mitomycin C augmentation. ( Anand, N; Arora, S, 2007) |
| "To evaluate long-term tonometric outcomes of trabeculectomy with adjunctive mitomycin C (MMC) and its efficacy in achieving a range of intraocular pressures (IOP) in phakic patients with open-angle glaucoma." | 3.73 | Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. ( Caprioli, J; Fontana, H; Lumba, J; Nouri-Mahdavi, K; Ralli, M, 2006) |
| "To determine the outcomes of trabeculectomy with mitomycin C (MMC) combined with direct cauterization of peripheral iris before iridectomy in the management of neovascular glaucoma (NVG), and to demonstrate the effect of this surgical technique on decreasing the incidence of intraoperative bleeding and early postoperative hyphema." | 3.73 | Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. ( Batman, A; Berker, N; Cankaya, B; Elgin, U; Simsek, T, 2006) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 3.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "Combined BGI and mitomycin C trabeculectomy provides excellent postoperative IOP control in patients with refractory glaucoma." | 3.71 | Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. ( Budenz, DL; Bueche, M; Feuer, W; Nguyen, QH; Nicolela, MT; Palmberg, PF; Scott, IU; Singh, K, 2002) |
| "The authors reviewed the charts of all patients of refractory developmental glaucoma who underwent mitomycin C-augmented trabeculectomy (0." | 3.70 | Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. ( Mandal, AK; Naduvilath, TJ; Prasad, K, 1999) |
| "5-Fluorouracil and MMC were found to be equally safe and effective adjuncts to primary trabeculectomy in the short- and medium-term postoperative periods." | 2.69 | Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. ( Baerveldt, GS; Budenz, DL; Chen, PP; Cohen, JS; Greenfield, DS; Mehta, K; Moster, MR; Shaikh, NM; Shaikh, S; Singh, K; Tsai, JC, 2000) |
| "Three procedures (6%) had intraoperative complications (2 iris prolapses, 1 subconjunctival hemorrhage)." | 1.43 | Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies. ( Ang, GS; Meagher, P; Wang, BZ, 2016) |
| "Postoperative complications were infrequent and comparable." | 1.42 | Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction. ( Agashe, A; Khandelwal, R; Khandelwal, RR; Majumdar, M; Raje, D; Rathi, A, 2015) |
| "The main intraoperative complications were microperforation of the trabeculodescemetic membrane (TDM) in 1 eye (2." | 1.42 | Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications. ( de la Cámara, J; Langhor, K; Langohr, K; Loscos, J; Parera, À; Romera, P; Sabala, A; Valldeperas, X, 2015) |
| "Mitomycin-C 0." | 1.33 | Transepithelial phototherapeutic keratectomy/photorefractive keratectomy with adjunctive mitomycin-C for complicated LASIK flaps. ( Candal, EM; Dennis, RF; Epstein, RJ; Majmudar, PA; Muller, LT, 2005) |
| "The prognosis for intraabdominal carcinomatosis is poor with conventional treatments and modalities." | 1.31 | Intraoperative modality of treatment for peritoneal carcinomatosis: use of hyperthermic interperitoneal chemoperfusion. ( Chase, VA; Hunley, EK; Kuhn, JA; Loggie, BW; McCarty, TM; Sutton, SW; Yancey, LW, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.17) | 18.2507 |
| 2000's | 25 (52.08) | 29.6817 |
| 2010's | 21 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wirbelauer, C | 1 |
| Mertens, CN | 1 |
| Rulli, E | 1 |
| Biagioli, E | 1 |
| Riva, I | 1 |
| Gambirasio, G | 1 |
| De Simone, I | 1 |
| Floriani, I | 1 |
| Quaranta, L | 1 |
| Suominen, S | 2 |
| Harju, M | 2 |
| Kurvinen, L | 1 |
| Vesti, E | 2 |
| Lang, SJ | 1 |
| Böhringer, D | 1 |
| Reinhard, T | 1 |
| Ribeiro, GC | 1 |
| Krueger, RR | 1 |
| Khandelwal, RR | 1 |
| Raje, D | 1 |
| Rathi, A | 1 |
| Agashe, A | 1 |
| Majumdar, M | 1 |
| Khandelwal, R | 1 |
| Loscos, J | 1 |
| Valldeperas, X | 1 |
| Langohr, K | 1 |
| Langhor, K | 1 |
| Parera, À | 1 |
| Romera, P | 1 |
| Sabala, A | 1 |
| de la Cámara, J | 1 |
| Sugimoto, Y | 1 |
| Mochizuki, H | 1 |
| Ohkubo, S | 1 |
| Higashide, T | 2 |
| Sugiyama, K | 2 |
| Kiuchi, Y | 1 |
| Wang, BZ | 1 |
| Ang, GS | 1 |
| Meagher, P | 1 |
| Ghanem, RC | 1 |
| Ghanem, VC | 1 |
| de Souza, DC | 1 |
| Kara-José, N | 1 |
| Ghanem, EA | 1 |
| Chin, S | 1 |
| Yoshida, K | 1 |
| Shinmei, Y | 1 |
| Aoyagi, M | 1 |
| Saito, A | 1 |
| Ohno, S | 1 |
| Okuda, T | 1 |
| Fukuhira, Y | 1 |
| Sumi, Y | 1 |
| Shimomura, M | 1 |
| Ihanamäki, T | 1 |
| Ollikainen, ML | 1 |
| Puustjärvi, TJ | 1 |
| Rekonen, PK | 1 |
| Uusitalo, HM | 1 |
| Teräsvirta, ME | 1 |
| Anand, N | 2 |
| Kumar, A | 1 |
| Gupta, A | 1 |
| de Benito-Llopis, L | 1 |
| Teus, MA | 1 |
| Khakshoor, H | 1 |
| Razavi, ME | 1 |
| Daneshvar, R | 1 |
| Shakeri, MT | 1 |
| Ghate, MF | 1 |
| Ghooshkhanehi, H | 1 |
| Forseto, Ados S | 1 |
| Marques, JC | 1 |
| Nosé, W | 1 |
| Oğuz, H | 1 |
| Gupta, VP | 1 |
| Gupta, P | 1 |
| Gupta, R | 1 |
| Mohr, Z | 1 |
| Hirche, C | 1 |
| Liebeskind, U | 1 |
| Rau, B | 1 |
| Hünerbein, M | 1 |
| Shehadeh-Mashor, R | 1 |
| Srinivasan, S | 1 |
| Boimer, C | 1 |
| Lee, K | 1 |
| Tomkins, O | 1 |
| Slomovic, AR | 1 |
| Ward, MS | 1 |
| Wandling, GR | 1 |
| Goins, KM | 1 |
| Sutphin, JE | 1 |
| Kitzmann, AS | 1 |
| Wagoner, MD | 1 |
| Hogewind, BF | 1 |
| Pijl, B | 1 |
| Hoyng, CB | 1 |
| Theelen, T | 1 |
| Budenz, DL | 2 |
| Scott, IU | 1 |
| Nguyen, QH | 1 |
| Feuer, W | 1 |
| Singh, K | 2 |
| Nicolela, MT | 1 |
| Bueche, M | 1 |
| Palmberg, PF | 1 |
| Sutton, SW | 1 |
| Yancey, LW | 1 |
| Chase, VA | 1 |
| Hunley, EK | 1 |
| McCarty, TM | 1 |
| Kuhn, JA | 1 |
| Loggie, BW | 1 |
| Al-Shahwan, S | 1 |
| Edward, DP | 1 |
| Muller, LT | 1 |
| Candal, EM | 1 |
| Epstein, RJ | 1 |
| Dennis, RF | 1 |
| Majmudar, PA | 1 |
| Landa, G | 1 |
| Pollack, A | 1 |
| Rachmiel, R | 1 |
| Bukelman, A | 1 |
| Marcovich, A | 1 |
| Zalish, M | 1 |
| Ralli, M | 2 |
| Nouri-Mahdavi, K | 3 |
| Caprioli, J | 3 |
| Fontana, H | 2 |
| Lumba, J | 1 |
| Shingleton, BJ | 1 |
| Price, RS | 1 |
| O'Donoghue, MW | 1 |
| Goyal, S | 1 |
| Elgin, U | 1 |
| Berker, N | 1 |
| Batman, A | 1 |
| Simsek, T | 1 |
| Cankaya, B | 1 |
| Park, UC | 1 |
| Ahn, JK | 1 |
| Park, KH | 1 |
| Yu, HG | 1 |
| Ou, JI | 1 |
| Manche, EE | 1 |
| Jamil, AL | 1 |
| Mills, RP | 1 |
| Chakraborty, D | 1 |
| Dutta Choudhury, B | 1 |
| Pérez, J | 1 |
| Rodríguez, MJ | 1 |
| Campaña, O | 1 |
| Veiras, S | 1 |
| Lorenzo, D | 1 |
| Lamas, M | 1 |
| Alvarez, J | 1 |
| Cheng, AC | 1 |
| Wong, VW | 1 |
| Rao, SK | 1 |
| Lam, DS | 1 |
| Arora, S | 1 |
| Li, G | 1 |
| O'Hearn, T | 1 |
| Yiu, S | 1 |
| Francis, BA | 1 |
| Carlson, DW | 1 |
| Alward, WL | 1 |
| Barad, JP | 1 |
| Zimmerman, MB | 1 |
| Carney, BL | 1 |
| Mandal, AK | 1 |
| Prasad, K | 1 |
| Naduvilath, TJ | 1 |
| Mehta, K | 1 |
| Shaikh, NM | 1 |
| Tsai, JC | 1 |
| Moster, MR | 1 |
| Greenfield, DS | 1 |
| Chen, PP | 1 |
| Cohen, JS | 1 |
| Baerveldt, GS | 1 |
| Shaikh, S | 1 |
| Piaton, JM | 2 |
| Keller, P | 2 |
| Limon, S | 2 |
| Quenot, S | 2 |
| Yamin, M | 1 |
| Quentin, CD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Deep Sclerectomy vs Xen in Solo Procedure: Comparative Study, Efficacy and Safety Profile[NCT05201378] | 282 participants (Actual) | Observational | 2021-07-15 | Completed | |||
| Intermediate Term Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin c in Trabeculectomy Surgery.[NCT00346489] | Phase 4 | 70 participants | Interventional | 2004-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for mitomycin and Complication, Intraoperative
| Article | Year |
|---|---|
[Role of Intraoperative Indirect Channelography in Glaucoma Stent Implantation].
Topics: Administration, Ophthalmic; Aged, 80 and over; Bevacizumab; Combined Modality Therapy; Female; Fluor | 2017 |
Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis.
Topics: Antimetabolites; Databases, Factual; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pr | 2013 |
8 trials available for mitomycin and Complication, Intraoperative
| Article | Year |
|---|---|
Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Humans; Intraocular Pressur | 2014 |
Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment Study.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctival Diseases; | 2015 |
Preoperative subpterygeal injection vs intraoperative mitomycin C for pterygium removal: comparison of results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; F | 2010 |
Feasibility of delayed hyperthermic intraperitoneal chemotherapy in case of unforeseen complications.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusio | 2011 |
Purified triamcinolone acetonide as antifibrotic adjunct in glaucoma filtering surgery.
Topics: Aged; Alkylating Agents; Conjunctiva; Female; Fibrosis; Glaucoma, Angle-Closure; Glaucoma, Open-Angl | 2013 |
Comparison of 1-site versus 2-site phacotrabeculectomy.
Topics: Antihypertensive Agents; Case-Control Studies; Cataract; Fluorouracil; Follow-Up Studies; Glaucoma; | 2006 |
A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Double-Blind Method; Female; Glaucoma; Humans; Intraoc | 1997 |
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Evaluation; Female; Fluorouracil | 2000 |
38 other studies available for mitomycin and Complication, Intraoperative
| Article | Year |
|---|---|
Surgical management of corneal limbal dermoids: retrospective study of different techniques and use of Mitomycin C.
Topics: Alkylating Agents; Amnion; Child; Child, Preschool; Combined Modality Therapy; Corneal Diseases; Der | 2014 |
Management of bilateral gas-bubble breakthrough during femtosecond LASIK in the presence of anterior basement membrane dystrophy.
Topics: Alkylating Agents; Basement Membrane; Corneal Dystrophies, Hereditary; Dry Eye Syndromes; Female; Hu | 2014 |
Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction.
Topics: Alkylating Agents; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-An | 2015 |
Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular | 2015 |
Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Female; Glaucoma; Glaucoma, Open-Angle; Human | 2016 |
Customized topography-guided photorefractive keratectomy with the MEL-70 platform and mitomycin C to correct hyperopia after radial keratotomy.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Corneal Topography; Female; Follow | 2008 |
Block suture for trabeculectomy using only 2 anchors.
Topics: Alkylating Agents; Conjunctiva; Glaucoma; Humans; Intraocular Pressure; Intraoperative Complications | 2008 |
A thin honeycomb-patterned film as an adhesion barrier in an animal model of glaucoma filtration surgery.
Topics: Absorbable Implants; Animals; Blister; Conjunctival Diseases; Disease Models, Animal; Filtering Surg | 2009 |
The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results.
Topics: Absorbable Implants; Aged; Anterior Chamber; Collagen; Conjunctival Diseases; Female; Follow-Up Stud | 2010 |
Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Exfoliation Syndrome; Female; Follow-Up Studies; | 2011 |
Primary phakic deep sclerectomy augmented with mitomycin C: long-term outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Female; Fo | 2011 |
Efficacy of surface ablation retreatments using mitomycin C.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Cornea; Humans; Intraoperative Com | 2010 |
Photorefractive keratectomy with mitomycin C after penetrating and lamellar keratoplasty.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Corneal Transplantation; Follow-Up Studies; Huma | 2010 |
Preoperative subpterygeal mitomycin C injection.
Topics: Alkylating Agents; Combined Modality Therapy; Conjunctiva; Humans; Injections; Intraoperative Care; | 2010 |
Preoperative subpterygeal injection versus intraoperative mitomycin C for pterygium removal: comparison of results and complications.
Topics: Alkylating Agents; Combined Modality Therapy; Conjunctiva; Humans; Injections; Intraoperative Care; | 2011 |
Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue.
Topics: Adult; Aged; Alkylating Agents; Combined Modality Therapy; Conjunctiva; Female; Fibrin Tissue Adhesi | 2011 |
Photorefractive keratectomy modification of postkeratoplasty anisometropic refractive errors.
Topics: Adult; Aged; Alkylating Agents; Anisometropia; Eyeglasses; Female; Humans; Intraoperative Complicati | 2013 |
Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glau | 2002 |
Intraoperative modality of treatment for peritoneal carcinomatosis: use of hyperthermic interperitoneal chemoperfusion.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma; Combined Modality Therapy; Female; | 2002 |
Foreign body granulomas secondary to retained sponge fragment following mitomycin C trabeculectomy.
Topics: Aged; Antibiotics, Antineoplastic; Cataract Extraction; Eye Foreign Bodies; Granuloma, Foreign-Body; | 2005 |
Transepithelial phototherapeutic keratectomy/photorefractive keratectomy with adjunctive mitomycin-C for complicated LASIK flaps.
Topics: Adult; Alkylating Agents; Chemotherapy, Adjuvant; Corneal Stroma; Epithelial Cells; Female; Humans; | 2005 |
Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma.
Topics: Aged; Cataract; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Outcomes of laser suture lysis after initial trabeculectomy with adjunctive mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Int | 2006 |
Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Glaucoma, O | 2006 |
Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Cohort Studies; Combined Modality Therapy; Female; | 2006 |
Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cautery; Combined Modality Therapy; Female; Glaucoma, Neov | 2006 |
Phacotrabeculectomy with mitomycin C in patients with uveitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Cataract; Co | 2006 |
Superficial keratectomy after epi-LASIK.
Topics: Adult; Corneal Diseases; Corneal Stroma; Corneal Topography; Female; Humans; Intraoperative Complica | 2006 |
Glaucoma tube or trabeculectomy? That is the question.
Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Glaucoma; Glaucoma Drainage Implants; Humans; | 2007 |
Phacotrabeculectomy study.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Fluorouracil; Glaucoma; Humans; Intraocular Pr | 2007 |
[Anesthetic management for scheduled peritonectomy and hyperthermic intraperitoneal chemotherapy in 20 patients].
Topics: Adult; Aged; Analgesia, Epidural; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Intraveno | 2006 |
Repositioning of free cap four days after LASIK.
Topics: Adult; Cornea; Drug Therapy, Combination; Humans; Intraoperative Complications; Keratomileusis, Lase | 2007 |
Surgical revision of failed filtration surgery with mitomycin C augmentation.
Topics: Aged; Antihypertensive Agents; Antimetabolites, Antineoplastic; Combined Modality Therapy; Female; F | 2007 |
Amniotic membrane transplantation for intraoperative conjunctival repair during trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Amnion; Combined Modality Therapy; Conjunctiva; Exfoliation Syndrome; Eye I | 2007 |
Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Glaucoma; Humans; Infant; Intra | 1999 |
[Holmium: YAG and neodymium: YAG laser assisted trans-canalicular dacryocystorhinostomy. Results of 317 first procedures].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antimetabolites; Child; Dacryocystorh | 2001 |
[Revision of failed dacryocystorhinostomies using the transcanalicular approach. Results of 118 procedures].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antimetabolites; Dacryocystorhinostom | 2001 |
[Results and complications after deep sclerectomy].
Topics: Cataract Extraction; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Intraoperative Compl | 2002 |